8 Tweedy Browne Vertex Pharmaceuticals Trades
Tweedy Browne's position in Vertex Pharmaceuticals is currently worth $14.8M. That's 1.32% of their equity portfolio (19th largest holding). Tweedy Browne started to build up the position in Vertex Pharmaceuticals in Q3 2023. Since then they sold 37.8k shares. The stake costed the investor $13M, netting the investor a gain of 13% so far.
Avg closing price
Price range
Sold 2.8% shares (-1.06k shares)
Q2 2025
Avg closing price
$460.78
Price range
$421.16
-
$509.50
Sold 5.7% shares (-2.32k shares)
Q1 2025
Avg closing price
$464.34
Price range
$402.49
-
$513.76
Sold 24.2% shares (-13k shares)
Q4 2024
Avg closing price
$461.09
Price range
$397.27
-
$516.74
Sold 1.4% shares (-746 shares)
Q3 2024
Avg closing price
$480.45
Price range
$460.00
-
$505.78
Sold 18.5% shares (-12.4k shares)
Q2 2024
Avg closing price
$434.05
Price range
$392.81
-
$485.53
Sold 0.1% shares (-65 shares)
Q1 2024
Avg closing price
$422.74
Price range
$407.69
-
$446.08
Sold 11.0% shares (-8.24k shares)
Q4 2023
Avg closing price
$369.42
Price range
$343.00
-
$410.68
New holding (+75k shares)
Q3 2023
Avg closing price
$349.73
Price range
$338.18
-
$362.46
News about Vertex Pharmaceuticals, Inc. and Tweedy Browne
Is Vertex Pharmaceuticals (VRTX) A Smart Long-Term Investment Choice?
Tweedy, Browne Company LLC, an investment management firm, published its ¡°International Value Fund¡± fourth quarter 2021 investor letter ¨C a copy of which can...